Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Bonavida

Showing results (111-120 of 192) with videos related to

Pageof 20
Sort By:
Bioorganic & Medicinal Chemistry|June 6, 2003
QSAR of apoptosis induction in various cancer cellsCorwin Hansch, Ali Jazirehi, Suresh Babu Mekapati, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 5, 2025
Opposing roles of YY1 and RKIP in cancer progression and therapy resistanceChristos Rigopoulos, Stavroula Baritaki, Ilias Georgakopoulos-Soares, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Prognostic significance of a combination of soluble Fas and soluble Fas ligand in the serum of patients with Ta bladder cancerYoichi Mizutani, Osamu Yoshida, Osamu Ukimura, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 2, 2017
Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancerStephanie Wottrich, Samantha Kaufhold, Emmanuel Chrysos, et al.
Molecular Cancer Therapeutics|April 14, 2007
Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1Stavroula Baritaki, Sara Huerta-Yepez, Toshiyuki Sakai, et al.
Cancer Research|October 7, 2004
Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by RituximabAli R Jazirehi, Mario I Vega, Devasis Chatterjee, et al.
Forum on Immunopathological Diseases and Therapeutics|November 5, 2013
Roles Each of Snail, Yin Yang 1 and RKIP in the Regulation of Tumor Cells Chemo-immuno-resistance to ApoptosisBenjamin Bonavida, Ali Jazirehi, Mario I Vega, et al.
Genes & Cancer|September 10, 2010
The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN CircuitKimberly Lin, Stavroula Baritaki, Loredana Militello, et al.
Cancers|March 28, 2024
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1Ana Dillen, Indy Bui, Megan Jung, et al.
Nitric Oxide : Biology and Chemistry|February 22, 2015
Repeated sub-optimal photodynamic treatments with pheophorbide a induce an epithelial mesenchymal transition in prostate cancer cells via nitric oxideEmilia Della Pietra, Francesca Simonella, Benjamin Bonavida, et al.
Pageof 20

Showing results (111-120 of 192) with videos related to

Sort By:
Pageof 20
Bioorganic & Medicinal Chemistry|June 6, 2003
QSAR of apoptosis induction in various cancer cellsCorwin Hansch, Ali Jazirehi, Suresh Babu Mekapati, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 5, 2025
Opposing roles of YY1 and RKIP in cancer progression and therapy resistanceChristos Rigopoulos, Stavroula Baritaki, Ilias Georgakopoulos-Soares, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Prognostic significance of a combination of soluble Fas and soluble Fas ligand in the serum of patients with Ta bladder cancerYoichi Mizutani, Osamu Yoshida, Osamu Ukimura, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 2, 2017
Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancerStephanie Wottrich, Samantha Kaufhold, Emmanuel Chrysos, et al.
Molecular Cancer Therapeutics|April 14, 2007
Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1Stavroula Baritaki, Sara Huerta-Yepez, Toshiyuki Sakai, et al.
Cancer Research|October 7, 2004
Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by RituximabAli R Jazirehi, Mario I Vega, Devasis Chatterjee, et al.
Forum on Immunopathological Diseases and Therapeutics|November 5, 2013
Roles Each of Snail, Yin Yang 1 and RKIP in the Regulation of Tumor Cells Chemo-immuno-resistance to ApoptosisBenjamin Bonavida, Ali Jazirehi, Mario I Vega, et al.
Genes & Cancer|September 10, 2010
The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN CircuitKimberly Lin, Stavroula Baritaki, Loredana Militello, et al.
Cancers|March 28, 2024
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1Ana Dillen, Indy Bui, Megan Jung, et al.
Nitric Oxide : Biology and Chemistry|February 22, 2015
Repeated sub-optimal photodynamic treatments with pheophorbide a induce an epithelial mesenchymal transition in prostate cancer cells via nitric oxideEmilia Della Pietra, Francesca Simonella, Benjamin Bonavida, et al.
Pageof 20